TEOAE System

Otoacoustic emissions (OAE) diagnostic system combining transient evoked (TEOAE) and distortion product (DPOAE) measurements for hearing screening and assessment. Used clinically for newborn hearing screening, pediatric audiology, and cochlear function evaluation. Enables non-invasive detection of outer hair cell function across frequency ranges.

PC-based module measuring transient evoked otoacoustic emissions for non-invasive cochlear function assessment. This system enables efficient hearing screening and inner ear diagnostics in both clinical and research settings.

The eAUDIO USB is an ENT diagnostic device that combines tympanography and rhinomanometry functions in a single system, reducing spatial and operational costs. It measures transient evoked otoacoustic emissions (TEOAE) for hearing assessment and evaluates nasal airflow and sinus function, enabling comprehensive audiological and rhinological evaluation in clinical settings.

Non-invasive diagnostic system for newborn and infant hearing assessment using acoustic otoemission technology. Enables early detection of hearing impairment in pediatric populations.

Otoacoustic emissions tester for early detection of hearing impairment in newborns and infants, enabling timely intervention and audiological assessment.

High-end medical device for hearing screening using otoacoustic emission technology, available in three model variants. Designed to protect hearing health through innovative technology and has received market approval.

A tabletop otoacoustic emission testing device model MSOAE-1T designed for hearing assessment and diagnosis. The stationary design is suitable for permanent installation in clinical laboratories and diagnostic facilities.

Hearing assessment device for children detecting auditory function abnormalities through acoustic measurement for early intervention.

A portable otoacoustic emission testing device model MSOAE-1H for hearing screening and diagnostic purposes. The portable design allows for flexible deployment in various clinical settings. It is part of the company's diagnostic series.

Newborn hearing screeners are diagnostic devices designed for early detection of hearing impairment in newborns and infants. These systems use automated auditory brainstem response (ABR) or otoacoustic emissions (OAE) technology to identify hearing loss during the critical neonatal screening window, enabling timely intervention and support for normal speech and language development.

Audiometric diagnostic equipment designed for hearing assessment in ENT clinics and practices. These systems measure auditory function and detect hearing impairments across various frequencies and intensities.

A comprehensive system for conducting digital hearing tests and audiometric evaluations. The platform enables precise measurement of auditory thresholds and identification of hearing impairment across different frequencies.